Home NDC 63459-416-99 GABITRIL
Product NDC 63459-416
Requested package NDC 63459-416-99
11-digit product format 634590416
Labeler code 63459
Product ID 63459-416_cdd94737-c30c-4035-8809-78c0ba68b88d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tiagabine Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Cephalon, LLC
Application NDA020646
Marketing category NDA
Marketing start 2001-04-01
Marketing end 0000-00-00
Substance TIAGABINE HYDROCHLORIDE
Active strength 16 mg/1
Pharmacologic classes Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 17 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 8fc7167e32ce…e96bbc724034…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 8 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020646-001 GABITRIL TIAGABINE HYDROCHLORIDE 4MG TABLET / ORAL AB RLD, RS 1997-09-30 N020646-002 GABITRIL TIAGABINE HYDROCHLORIDE 12MG TABLET / ORAL AB RLD 1997-09-30 N020646-003 GABITRIL TIAGABINE HYDROCHLORIDE 16MG TABLET / ORAL AB RLD 1997-09-30 N020646-004 GABITRIL TIAGABINE HYDROCHLORIDE 20MG TABLET / ORAL 1997-09-30 N020646-005 GABITRIL TIAGABINE HYDROCHLORIDE 2MG TABLET / ORAL AB RLD 1999-04-16 N020646-006 GABITRIL TIAGABINE HYDROCHLORIDE 6MG TABLET / ORAL 2005-11-29 N020646-007 GABITRIL TIAGABINE HYDROCHLORIDE 8MG TABLET / ORAL 2005-11-29 N020646-008 GABITRIL TIAGABINE HYDROCHLORIDE 10MG TABLET / ORAL 2005-11-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 9 · 360 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N020646-001 GABITRIL 4MG TABLET / ORAL AB RLD, RS 1997-09-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-002 GABITRIL 12MG TABLET / ORAL AB RLD 1997-09-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-003 GABITRIL 16MG TABLET / ORAL AB RLD 1997-09-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-004 GABITRIL 20MG TABLET / ORAL 1997-09-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-005 GABITRIL 2MG TABLET / ORAL AB RLD 1999-04-16 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-006 GABITRIL 6MG TABLET / ORAL 2005-11-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-007 GABITRIL 8MG TABLET / ORAL 2005-11-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020646-008 GABITRIL 10MG TABLET / ORAL 2005-11-29 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N020646-001 GABITRIL 4MG TABLET / ORAL AB RLD, RS 1997-09-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-002 GABITRIL 12MG TABLET / ORAL AB RLD 1997-09-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-003 GABITRIL 16MG TABLET / ORAL AB RLD 1997-09-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-004 GABITRIL 20MG TABLET / ORAL 1997-09-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-005 GABITRIL 2MG TABLET / ORAL AB RLD 1999-04-16 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-006 GABITRIL 6MG TABLET / ORAL 2005-11-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-007 GABITRIL 8MG TABLET / ORAL 2005-11-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020646-008 GABITRIL 10MG TABLET / ORAL 2005-11-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020646-001 GABITRIL 4MG TABLET / ORAL AB RLD, RS 1997-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-002 GABITRIL 12MG TABLET / ORAL AB RLD 1997-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-003 GABITRIL 16MG TABLET / ORAL AB RLD 1997-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-004 GABITRIL 20MG TABLET / ORAL 1997-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-005 GABITRIL 2MG TABLET / ORAL AB RLD 1999-04-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-006 GABITRIL 6MG TABLET / ORAL 2005-11-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-007 GABITRIL 8MG TABLET / ORAL 2005-11-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020646-008 GABITRIL 10MG TABLET / ORAL 2005-11-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020646-001 GABITRIL 4MG TABLET / ORAL AB RLD, RS 1997-09-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-002 GABITRIL 12MG TABLET / ORAL AB RLD 1997-09-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-003 GABITRIL 16MG TABLET / ORAL AB RLD 1997-09-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-004 GABITRIL 20MG TABLET / ORAL 1997-09-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-005 GABITRIL 2MG TABLET / ORAL AB RLD 1999-04-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-006 GABITRIL 6MG TABLET / ORAL 2005-11-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-007 GABITRIL 8MG TABLET / ORAL 2005-11-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020646-008 GABITRIL 10MG TABLET / ORAL 2005-11-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020646-001 GABITRIL 4MG TABLET / ORAL AB RLD, RS 1997-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-002 GABITRIL 12MG TABLET / ORAL AB RLD 1997-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-003 GABITRIL 16MG TABLET / ORAL AB RLD 1997-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-004 GABITRIL 20MG TABLET / ORAL 1997-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-005 GABITRIL 2MG TABLET / ORAL AB RLD 1999-04-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-006 GABITRIL 6MG TABLET / ORAL 2005-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-007 GABITRIL 8MG TABLET / ORAL 2005-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020646-008 GABITRIL 10MG TABLET / ORAL 2005-11-29 011fe1cb6892…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 180 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product No
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TIAGABINE HYDROCHLORIDE 16 mg/1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TIAGABINE HYDROCHLORIDE ACTIVE INGREDIENT DQH6T6D8OY GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 TIAGABINE ACTIVE MOIETY Z80I64HMNP GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 ANHYDROUS LACTOSE INACTIVE INGREDIENT 3SY5LH9PMK GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 ASCORBIC ACID INACTIVE INGREDIENT PQ6CK8PD0R GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 HYDROGENATED SOYBEAN OIL INACTIVE INGREDIENT A2M91M918C GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP GABITRIL (TIAGABINE HYDROCHLORIDE) TABLET, FILM COATED [CEPHALON, INCORPORATED] 15
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Status 63459-416-99 63459041699 31115 TABLET, FILM COATED in 1 DRUM (63459-416-99) 08-FEB-10 Current